Focus Issue: Valvular Heart DiseaseClinical ResearchComparison of the Hemodynamic Performance of Percutaneous and Surgical Bioprostheses for the Treatment of Severe Aortic Stenosis
Clinical Research
Under an Elsevier user license
open archive
Key Words
aortic stenosis
heart valve prosthesis
percutaneous aortic valve implantation
aortic valve replacement
bioprosthesis
hemodynamics
Abbreviations and Acronyms
AR
aortic regurgitation
EOA
effective orifice area
EOAi
indexed effective orifice area
LVEF
left ventricular ejection fraction
PAVI
percutaneous aortic valve implantation
PPM
prosthesis-patient mismatch
SAVR
surgical aortic valve replacement
Cited by (0)
This study was funded, in part, by a grant (MOP 57745) of the Canadian Institutes of Health Research, Ottawa, Ontario, Canada. Dr. Pibarot holds the Canada Research Chair in Valvular Heart Disease, Canadian Institutes of Health Research, and has received honoraria from Edwards Lifesciences, Inc., Sorin Medical, St. Jude Medical, and Medtronic. Dr. Rodés-Cabau is a consultant for Edwards Lifesciences, Inc. Dr. Webb is a consultant to Edwards Lifesciences, Inc., St. Jude Medical, Guided Delivery Systems, and Kardium. Dr. Dumont served in a proctorship for transapical aortic valve replacement for Edwards Lifesciences, Inc.
Copyright © 2009 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.